← Eichor
Study identifier: NCT07244705 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC

Condition: Colorectal Cancer (Diagnosis) · Colorectal Cancer Metastatic · Colorectal Cancer (CRC)  ·  Sponsor: Anbogen Therapeutics, Inc.

PhasePhase 1/Phase 2
Planned participants66
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to evaluate the safety and tolerability of escalating doses of ABT-301 in combination with fixed doses of tislelizumab 200 mg IV infusion and bevacizumab 7.5 mg/kg IV infusion Q3W, in participants with pMMR/non-MSI-H colorectal cancer (CRC). It will also determine the maximum tolerated dose (MTD) and select the recommended Phase 2 dose (RP2D) of ABT-301. Participants will receive ABT-301 administered once daily (QD ±3 hours) or twice daily (Q12H ±3 hours, at least 9 hours apart) with water in 21-day treatment cycles. Tislelizumab 200 mg IV and bevacizumab 7.5 mg/kg IV Q3W will be given in both parts of the study.

This description comes directly from the study's public registry record.

Talk to the study team

Ryan Hua  ·  +886-2-8979-8616  ·  abt301-103@anbogen.com

Always discuss trial participation with your own doctor first.

Locations (15)

Liverpool Cancer Therapy CentreLiverpool, New South Wales, AustraliaNot Yet Recruiting
Macquarie University Hospital (MUH)Macquarie Park, New South Wales, AustraliaNot Yet Recruiting
Scientia Clinical ResearchRandwick, New South Wales, AustraliaRecruiting
Greenslopes Private Hospital - Cyril Gilbert Cancer CentreGreenslopes, Queensland, AustraliaNot Yet Recruiting
The Queen Elizabeth Hospital (TQEH)Woodville South, South Australia, AustraliaNot Yet Recruiting
Monash University - Faculty of Medicine, Nursing and Health SciencesClayton, Victoria, AustraliaNot Yet Recruiting
Austin Health - Cancer Clinical Trials Centre (CCTC)Heidelberg, Victoria, AustraliaNot Yet Recruiting
Linear Clinical ResearchNedlands, Western Australia, AustraliaNot Yet Recruiting
Kaohsiung Medical University Chung-Ho Memorial HospitalKaohsiung City, TaiwanNot Yet Recruiting
E-Da Cancer HospitalKaohsiung City, TaiwanNot Yet Recruiting
Chang Gung Medical Foundation, Kaohsiung Chang Gung Memorial HospitalKaohsiung City, TaiwanNot Yet Recruiting
Taipei Medical University Shuang Ho Hospital, Ministry of Health and WelfareNew Taipei City, TaiwanNot Yet Recruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07244705